A-Mode vs PalmScan Ultrasonography: Biometric Measurements.

Sponsor
Asociación para Evitar la Ceguera en México (Other)
Overall Status
Completed
CT.gov ID
NCT00804869
Collaborator
(none)
1

Study Details

Study Description

Brief Summary

Ultrasonography has become a critical ancillary test in the clinical practice of ophthalmology. It is commonly used as a standardized method for assessing intraocular biometry. The PalmScan ultrasonography (PsU) is a portable A-scan device that uses the same principles as the standard A-scan. The aim of the study is to compare the reliability of their measurements, in order to use them indistinctively.

Condition or Disease Intervention/Treatment Phase
  • Device: PalmScan A2000 ultrasonography system (Micro Medical Devices, Calabasas, CA)
  • Device: Standard A-mode ultrasound (Eye Cubed™, Ellex, Adelaide, Australia).

Study Design

Study Type:
Observational
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Standard A-Mode Ultrasonography vs PalmScan Ultrasonography: Biometric Measurements.
Study Start Date :
Oct 1, 2008
Actual Primary Completion Date :
Dec 1, 2008

Arms and Interventions

Arm Intervention/Treatment
1

PalmScan biometric group

Device: PalmScan A2000 ultrasonography system (Micro Medical Devices, Calabasas, CA)
PalmScan biometric measurements

2

A-mode ultrasonography biometric group

Device: Standard A-mode ultrasound (Eye Cubed™, Ellex, Adelaide, Australia).
A-mode biometric measurements group

Outcome Measures

Primary Outcome Measures

  1. axial length (AL). [during examination]

  2. Anterior Chamber Deep (ACD) [during examination]

  3. Lens Thickness (LT) [during examination]

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients with indication for a standard A-mode ultrasound
Exclusion Criteria:
  • No superficial anormalities.

  • Patients with external injuries.

  • Intraocular silicon oil.

  • Retinal detachment

  • Significant ocular pathologies.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Asociación para Evitar la Ceguera en México Mexico DF Mexico 04030

Sponsors and Collaborators

  • Asociación para Evitar la Ceguera en México

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00804869
Other Study ID Numbers:
  • APEC-037
First Posted:
Dec 9, 2008
Last Update Posted:
Dec 9, 2008
Last Verified:
Dec 1, 2008

Study Results

No Results Posted as of Dec 9, 2008